Please see the attached paper on assessing the performance of a transcriptomic signature of tuberculosis (RISK11) using an RCT study design. Scriba_2021.pdf (1.7 MB)
Related topics
Topic | Replies | Views | Activity | |
---|---|---|---|---|
Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis | 0 | 395 | August 25, 2020 | |
Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis | 0 | 473 | September 7, 2020 | |
Transcriptional biomarkers for predicting development of TB: progress and clinical considerations | 0 | 454 | January 17, 2020 | |
A systematic comparison of 16 gene signatures for TB diagnosis | 0 | 585 | May 6, 2019 | |
Value of transcriptomics in understanding immune response and TB diagnosis | 0 | 381 | April 29, 2019 |